Patent · US Active

Extended, delayed and immediate release formulation method of manufacturing and use thereof

US10105330B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 1, 2015
Grant dateOct 23, 2018
Priority date
Expiry dateNov 23, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions for reducing the frequency of urination and methods of manufacturing the compositions are disclosed. The compositions comprises a first component having an immediate-release subcomponent and an extended-release subcomponent, wherein the first component is formulated to release the subcomponents immediately after administration; and a second component comprising an immediate-release subcomponent and an extended-release subcomponent, wherein the second component is formulated for a delayed-release of the subcomponents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.